The effect of Ginkgo biloba Extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats

American Journal of Chinese Medicine

Volumn 32, Issue 1, 2004, Pages 21-31

  Zhang, Chunqing ^a   Zu, Juren ^a   Shi, Hengmei ^a   Liu, Jiyong ^a   Qin, Chengyong ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Carbon tetrachloride; Endothelial cell; Ginkgo biloba Extract; Hepatic sinusoid; Microcirculation; Rats; Transmission electron microcirculation

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; ENDOTHELIN 1; FLAVONOID GLYCOSIDE; GINKGO BILOBA EXTRACT; LIPID; MALONALDEHYDE; NITRIC OXIDE; SODIUM CHLORIDE; TERPENOID; THROMBOCYTE ACTIVATING FACTOR; DIAGNOSTIC AGENT; GINKGO BILOBA EXTRACT 761; PLANT EXTRACT; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; CAPILLARY; CELL AGGREGATION; CELL DAMAGE; CELL PROTECTION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HEMODYNAMIC PARAMETERS; LIPID PEROXIDATION; LIVER CIRCULATION; LIVER INJURY; LIVER SINUSOID; MALE; MICROCIRCULATION; MICROTHROMBUS; NONHUMAN; RADIOIMMUNOASSAY; RAT; RAT STRAIN; SPECTROPHOTOMETRY; TISSUE LEVEL; TISSUE SECTION; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; VASCULARIZATION; ANIMAL; CYTOLOGY; DRUG EFFECT; ELECTRON MICROSCOPY; GINKGO BILOBA; INJURY; LIVER; METABOLISM; PHYTOTHERAPY; PLANT LEAF; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; CARBON TETRACHLORIDE; ENDOTHELIAL CELLS; ENDOTHELIN-1; GINKGO BILOBA; LIVER; MALE; MALONDIALDEHYDE; MICROCIRCULATION; MICROSCOPY, ELECTRON; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLATELET ACTIVATING FACTOR; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 3042668593     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04001692     Document Type: Article

References (28)

1. Ahlemeyer, B., A. Mowes and J. Krieglstein. Inhibition of serum deprivation and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur. J. Pharmacol. 367: 423-430, 1999.
2. Barton, M., T. Lattmann, L.V. d'Uscio, T.F. Luscher and S. Shaw. Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: implications for the age-dependent increase of cardiorenal disease. J. Cardiovasc. Pharmacol. 36: S153-156, 2000.
3. Belougne, E., O. Aguejouf, P. Imbault, O.F. Azougagh, F. Doutremepuich, M.T. Droy-Lefaix and C. Doutremepuich. Experimental thrombosis model induced by laser beam: application of aspirin and an extract of Ginkgo biloba: EGb 761. Thromb. Res. 82: 453-458, 1996.
4. Carvalho-Tavares, J., A. Fox-Robichand and P. Kubes. Assessment of the mechanism of juxtacrine activation and adhesion of leukocytes in liver microcirculation. Am. J. Physiol. 276: G828-834, 1999.
5. Chen, X., L. Liu and Z. Li. Cardiovascular protective effects and NO-mediated cerebrovasorelaxant effect of extract of Ginkgo biloba leaves. Zhonghua Yi Yu Za Zhi 78: 692-695, 1998.
6. Cheung, F., Y.L. Siow, W.Z. Chen and O. Karmin. Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem. Pharmacol. 58: 1665-1673, 1999.
7. Clostre, F. Ginkgo biloba extract (EGB 761): State of knowledge in the dawn of the year 2000. Ann. Pharm. Fr. 57(Suppl. 1): S18-88, 1999.
8. Diamond, B.J., S.C. Shiflett, N. Feiwel, R.J. Matheis, O. Noskin, J.A. Richards and N.E. Schoenberger. Ginkgo biloba extract: mechanisms and clinical indications. Arch. Phys. Med. Rehabil. 81: 668-678, 2000.
9. Farzaneh-Far, R. and K. Moore. Nitric oxide and the liver. Liver 21: 161-174, 2001.
10. Gaudio, E., L. Pannarale, A. Franchitto, P. Onori and G. Marinozzi. Hepatic microcirculation as a morpho-functional basis for the metabolic zonation in normal and pathological rat liver. Ital. J. Anat. Embryol. 100(Suppl.): 419-428, 1995.
11. Jastreboff, P.J., S. Zhou, M.M. Jastreboff, U. Kwapisz and U. Gryczynska. Attenuation of salicylate-induced tinnitus by Ginkgo biloba extract in rats. Audiol. Neurootol. 2: 197-212, 1997.
12. Lagrue, G., A. Behar, M. Kazandjian and K. Rahbar. Idiopathic cyclic edema: the role of capillary hyperpermeability and its correction by Ginkgo biloba extract. Presse Med. 15: 1550-1553, 1986.
13. Maeda, T., Y. Katayama, T. Kawamata, N. Aoyama and T. Mori. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. Acta Neurochir. Suppl. (Wien.) 70: 102-105, 1997.
14. Minor, T., W. Isselhard and T. Yamaguchi. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia. J. Surg. Res. 58: 536-540, 1995.
15. Oda, M., J.Y. Han, H. Yokomori. Local regulators of hepatic sinusoidal microcirculation: recent advances. Clin. Hemorheol. Microcirc. 23: 84-94, 2000a.
16. Oda, M., J.Y. Han and M. Nakamura. Endothelial cell dysfunction in microvasculature: relevance to disease processes. Clin. Hemorheol. Microcirc. 23: 199-211, 2000b.
17. Ohkawa, H. and N. Ohishi and K. Yagi. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358, 1979.
18. Ota, T., R. Hirai, A. Urakami, H. Soga, S. Nawa and N. Shimizu. Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbance and hepatic cell injury after ischemia/reperfusion. Surg. Today 27: 313-320, 1997.
19. Poli, G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med. 21: 49-98, 2000.
20. Qian, C., C.T. Liu and C.J. Peters. Increased platelet-activating factor (PAF) concentrations in hearts and lungs of Pichinde virus-infected guinea pigs. J. Lipid Mediat. 5: 261-270, 1992.
21. Ribaldi, E., M. Guerra, A.M. Mezzasoma, N, Staffolani, G. Goracci and P. Gresele. PAF levels in saliva are regulated by inflammatory cells. J. Periodontal. Res. 33: 237-241, 1998.
22. Schweizer, J. and C. Hautmann. Comparison of two dosages of Ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb: a randomised, double-blind, multicentric clinical trial. Arzneimittelforschung 49: 900-904, 1999.
23. Shen, J., J. Wang, B. Zhao, J. Hou, T. Gao and W. Xin. Effects of EGB 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochem. Biophys. Acta 28: 228-236, 1998.
24. Topp, S., W.T. Knoefel, A. Schutte, S. Brilloff, X. Rogiers and M. Gundlach. Ginkgo biloba (EGb 761) improves microcirculation after warm ischemia of the rat liver. Transplant. Proc. 33: 979-981, 2001.
25. Uhlmann, D., H. Witzigmann, N. Senninger, J. Hauss and H.U. Spiegel. Protective role of an endothelin-converting enzyme inhibitor in hepatic ischemia/reperfusion injury. Microvasc. Res. 62: 43-54, 2001.
26. Varga, E., A. Bodi, P. Ferdinandy, M.T. Droy-Lefailax, L.E. Blasig and A. Tosaki. The protective effect of EGB 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J. Cardiovasc. Pharmacol. 34: 711-717, 1999.
27. Vollmar, B., S. Siegmund and M.D. Menger. An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. Hepatology 27: 1544-1553, 1998.
28. 4 rats. Zhong Xi Yi Gangbing Za Zhi 10: 176-179, 2001.